tm logo
MZN
Live/Registered
REGISTERED

on 21 Jun 2022

Last Applicant/ Owned by

3F, C&H Bldg 35 Teheran-ro 87-Gil

Seoul

KR

06167

Serial Number

88397526 filed on 23rd Apr 2019

Registration Number

6763102 registered on 21st Jun 2022

in the Principal Register

Correspondent Address

Howard M. Gitten

LEWIS BRISBOIS BISGAARD & SMITH, LLP

550 W. Adams Street, Suite 300

Chicago IL 60661

Filing Basis

1. intent to use

Disclaimer

NO DATA

MZN

Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely, single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation

Mark Details


Serial Number

No 88397526

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 40836-6260US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Jun 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
21st Jun 2022REGISTERED-PRINCIPAL REGISTER
05th Apr 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05th Apr 2022PUBLISHED FOR OPPOSITION
16th Mar 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Mar 2022TEAS EXTENSION RECEIVED
03rd Mar 2022CASE RETURNED TO EXAMINATION
03rd Mar 2022NOTICE OF ALLOWANCE CANCELLED
23rd Feb 2022ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
23rd Feb 2022PETITION TO DIRECTOR - CHANGE BASIS - GRANTED